IL-1 inhibitors are effective in the treatment of AOSD-related Macrophage Activation Syndrome (MAS) [4], although cases of MAS occurring during treatment with these drugs are reported [2b]. This evidence concerns the gene IL1B and macrophage activation syndrome.